
Loading, please wait...

Loading, please wait...

Camellia oil, derived from Camellia oleifera Abel., has been a staple in East Asian traditional medicine for centuries, particularly for treating burns and inflammatory conditions. While it is rich in phytosterols like β-sitosterol, its clinical application has been hindered by poor bioavailability. Recent advancements in Camellia oil nanotechnology are now addressing these limitations. By engineering a photothermally responsive nanoplatform, researchers have paved the way for the controlled release of these potent bioactives.
Initially, network pharmacology and molecular docking were employed to identify β-sitosterol as the primary active component within Camellia oil. To enhance its delivery, a specialized liposomal system was designed by co-loading β-sitosterol with carbon quantum dots derived from theabrownin. These liposomes demonstrated a remarkable photothermal conversion efficiency of 46.6%. This capability allows for temperature-dependent cargo release, ensuring that the bioactives reach their target in a controlled manner.
In vitro studies have shown that this system possesses significant radical-scavenging abilities, including an 89.4% effectiveness against superoxide. Furthermore, in macrophage models stimulated by lipopolysaccharides, the system effectively reduced intracellular reactive oxygen species. It also downregulated critical pro-inflammatory genes such as iNOS, TNF-α, and IL-6. Notably, iNOS mRNA expression was inhibited by 71.6%. Consequently, the system promoted a functional shift toward inflammatory resolution by upregulating the reparative gene CD206.
Transcriptomic analysis revealed that the liposomal system reverses inflammatory homeostasis impairment. It achieves this by modulating the balance between inflammatory and metabolic modules. Bioinformatic predictions indicate that this process is largely driven by the regulatory node Pparg. This integration of natural bioactives with Camellia oil nanotechnology coordinates immune homeostasis, offering a high-value strategy for utilizing woody oil crops as functional medical ingredients.
The system uses carbon quantum dots to convert light into heat, which triggers the liposomes to release β-sitosterol at specific temperatures. This overcomes the natural poor solubility and absorption of phytosterols.
The treatment shifts macrophages from a pro-inflammatory (M1) state to a reparative (M2) state. This is crucial for resolving chronic inflammation and promoting tissue healing.
While currently in the pre-clinical phase, the use of nanotechnology to enhance traditional oils aligns with India's growing focus on integrative medicine and advanced drug delivery systems for inflammatory disorders.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
Chen Y et al. β-Sitosterol from Camellia oil integrated photothermal liposomes increasing redox-balanced anti-inflammation in macrophages. J Sci Food Agric. 2026 May 27. doi: 10.1002/jsfa.70755. PMID: 42204380.
Anh HNQ, et al. A review on Camellia oleifera Abel.: A valuable material in food and medicine. Food Sci. Preserv. 2024;31(3):333-345.
Wang J, et al. β-Sitosterol modulates macrophage polarization and attenuates rheumatoid inflammation in mice. Inflammopharmacology. 2020;28(1):123-134.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a photothermal liposomal system to enhance the delivery of β-sitosterol from Camellia oil, significantly reducing inflammation....
4 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today